What is the clinical evidence from this study?

Study design: Review. Population: Prediabetes. Intervention: Prediabetes remission.

What does this research mean for the field?

Sustained remission from prediabetes to normoglycemia is an achievable and clinically meaningful prevention endpoint that reduces long-term diabetes incidence and cardiovascular risk, providing a scalable framework for routine care in low-resource settings. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To evaluate prediabetes remission to normoglycemia as a feasible, clinically meaningful therapeutic endpoint for diabetes prevention in resource-constrained environments.

September 2, 2026Open Access

Prediabetes Remission as a Pragmatic and Scalable Prevention Endpoint in Low-resource Settings

View Full Paper

Ask AI

Bookmark

Key result

Prediabetes remission offers a pragmatic target to cut diabetes incidence and long-term cardiovascular risk.

Design

Review

Authors

BBBishwajit BhowmikCentre for Global Health Research TSTasnima SiddiqueeBangladesh University SJShashank R JoshiLilavati Hospital & Research Centre

Discussion

Member takes

Implication

Reframing prediabetes management to focus on sustained remission to normoglycemia may provide a pragmatic and scalable prevention endpoint that reduces long-term cardiovascular risk.

Key Points

To evaluate prediabetes remission to normoglycemia as a feasible, clinically meaningful therapeutic endpoint for diabetes prevention in resource-constrained environments.
Synthesized long-term follow-up findings from landmark clinical trials assessing outcomes of regression from prediabetes to normoglycemia.
Reviewed community-based and lifestyle intervention trials conducted in real-world, resource-constrained settings.
Reversion to normoglycemia yields sustained reductions in type 2 diabetes incidence compared with persistent prediabetes.
Prediabetes remission is associated with lower long-term risks of cardiovascular mortality and hospitalizations for heart failure.
Pragmatic lifestyle and community interventions achieve achievable prediabetes remission in resource-limited environments.

PICO

Population

Prediabetes

Intervention / Comparator

Prediabetes remission

Reframing prediabetes management to focus on sustained remission to normoglycemia may provide a pragmatic and scalable prevention endpoint that reduces long-term cardiovascular risk.

Cite This Study

Bhowmik et al. (2026) conducted a review in Prediabetes. Prediabetes remission was evaluated. Prediabetes remission to normoglycemia is proposed as a pragmatic and scalable prevention endpoint to reduce diabetes incidence and long-term cardiovascular risk.

synapsesocial.com/papers/6a97e29ec562ede874ec6cd1 https://doi.org/10.5005/jodec-11035-0012

View Full Paper

Ask AI

Bookmark

Implication

Reframing prediabetes management to focus on sustained remission to normoglycemia may provide a pragmatic and scalable prevention endpoint that reduces long-term cardiovascular risk.

Prediabetes Remission as a Pragmatic and Scalable Prevention Endpoint in Low-resource Settings

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Prediabetes Remission as a Pragmatic and Scalable Prevention Endpoint in Low-resource Settings

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Also Consider